Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108

20260 citationsJournal Articlegold Open Access

Authors

Suein Choi · Catholic University of Korea

Ja Min Byun · Seoul National University Hospital

Si Eun Oh · The Catholic University of Korea Seoul St. Mary's Hospital

Jinseon Han · Catholic University of Korea

Seungpil Jung · Catholic University of Korea

Seunghoon Han · Catholic University of Korea

Seung-Hwan Shin

Abstract

The MM-CI provides a simple, objective, and clinically applicable tool for comorbidity-based risk stratification in MM. It outperforms existing models and may support treatment decisions in real-world practice.

Topics & Keywords

Multiple Myeloma Research and Treatments Multiple and Secondary Primary Cancers Cancer-related cognitive impairment studies

Publication Details

Published in: Blood Cancer Journal

Volume 16, Issue 1

DOI: 10.1038/s41408-026-01475-1

Field-Weighted Citation Impact: 0.00

Command Palette

Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108

Authors

Abstract

Topics & Keywords

Publication Details